MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Force Estimation as a Method to Assess Proprioception in Parkinson’s Disease Patients

    M. Wilken, G. Bianchi, M. Martínez Sucre, C. Cruz Molina, G. Noel, D. Andres, M. Merello (Buenos Aires, Argentina)

    Objective: To evaluate the validity of force estimation as a method for assessing proprioception, and to determine if proprioception is impaired in Parkinson's disease (PD)…
  • 2025 International Congress

    Analysis of statistical data on patients with Parkinson’s disease.

    R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)

    Objective: To determine the spread of the disease by sex and age groups among the population of Uzbekistan. Background: Parkinson's disease is quite relevant throughout…
  • 2025 International Congress

    Evaluating the Efficacy of Home-Based Exercise Interventions for Individuals with Mild to Moderate Parkinson’s Disease: A Systematic Review

    M. M. Elsayed, M. Alomari, N. Abdeltawab, O. Hafez, N. Elmestkawy, M. Mustafa, A. Abdelsalhin, S. A. Hassan (Mansoura, Egypt)

    Objective: To systematically evaluate the effectiveness of HBEI on motor symptoms, balance, and overall well-being in individuals with mild to moderate PD, providing insights into…
  • 2025 International Congress

    Alpha-Synuclein Accumulation-Attenuating Effect of Brain-Derived Neurotrophic Factor in Primary Cell Culture Model of Parkinson’s Disease

    I. Hlushchuk, MT. Airavaara (Helsinki, Finland)

    Objective: To explore the role of neurotrophic signaling pathways in modulating the effect of brain-derived neurotrophic factor (BDNF) on pre-formed fibrils (PFFs)- induced alpha-synuclein (aSyn)…
  • 2025 International Congress

    Glial interaction with Parkinsonian disorders biomarkers: alpha-synuclein, dopaminergic dysfunction and clinical stages

    L. Souza, D. Teixeira, G. Pereira, E. Zimmer, W. Borelli, A. Schuh (Porto Alegre, Brazil)

    Objective: We aim to investigated the relationship between glial markers and Parkinson's disease. Background: Neuronal α-Synuclein Disease (NSD) has recently been proposed as a framework for…
  • 2025 International Congress

    Improving Motor and Non-motor Symptoms in Parkinson’s Disease: A combined Pharmaceutical and Digital Approach Targeting Parallel Neural Circuits

    A. Amedi, N. Saporta, T. Tamir, R. Sivan Hoffmann, M. Catalogna (Herzliya, Israel)

    Objective: We aimed to demonstrate the parallel neural mechanisms underlying the effects of combining standard levodopa treatment with the DopApp digital intervention on motor and…
  • 2025 International Congress

    GBA1 deficiency promotes the spread of Lewy pathology

    S. Fish, A. Park, J. Weiss, M. Kim, E. Chiu, M. Callier, S. Yu, M. Davis (Seattle, USA)

    Objective: To elucidate how GBA1 deficiency promotes the spread of Lewy pathology from cell to cell. Background: Mutations in the gene glucosidase, beta acid 1 (GBA1) not…
  • 2025 International Congress

    Longitudinal Effects of Initial Deep Brain Stimulation Settings on Force-Tracking Brain Activation and Motor Performance in Parkinson’s Disease

    A. Vijayakumari, C. Piccinin, T. Lopez Gonzalez, J. Alberts, P. Bhattacharyya, M. Lowe, B. Walter (Cleveland, USA)

    Objective: To evaluate changes in force-tracking (FT) fMRI activation patterns and motor performance over time using initial deep brain stimulation (DBS) settings optimized after three…
  • 2025 International Congress

    A novel potential imaging biomarker for Parkinson’s disease: Optical Coherence Tomography.

    G. Napoli, R. Santangelo, G. Rugarli, R. Balestrino, E. Sarasso, L. Ferini-Strambi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: This observational cross-sectional study aims to explore the thickness of retinal layers in patients within the PD continuum, patients with isolated REM Sleep Behavior…
  • 2025 International Congress

    Assessing Genome-wide Genetic Risk for Parkinson’s Disease Age at Onset in European Sub-Populations: from the Global Parkinson’s Genetics Program

    GP2. Parkinson'S_genetics_program (Bethesda, USA)

    Objective: To identify the genetic determinants of Parkinson’s disease (PD) age at onset (AAO) within and across genetically determined European ancestries (European, Ashkenazi Jewish, Finnish,…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley